Cited by 1Amyotrophic Lateral Sclerosis ResearchAlzheimer's disease research and treatmentsHereditary Neurological Disorders

Genetics of neurodegenerative diseases

Open access
Pulst, Stefan M.·2016·Neurology Genetics

Abstract

This issue contains a number of articles on neurodegenerative diseases, most of them genotypically analyzed with next-generation sequencing. Readers will find articles identifying potential mutations in new genes, articles examining different phenotypes associated with variation in the same gene, and a report showing an unusual phenotype associated with a known mutation in the PRNP gene. Finally, the imaging phenotypes of mutations in 2 different frontotemporal lobar dysfunction (FTLD) genes are compared.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1212/nxg.0000000000000052

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The TTC3 gene is involved in the regulation of AKT signaling and is related with immune tolerance and neuronal cell survival.

    “Furthermore, the TTC3 gene is also involved in the regulation of AKT signaling and is related with immune tolerance and neuronal cell survival (Chen et al., 2003; Liu et al., 2009; Pulst, 2016).”

    From Identification of Candidate Signature Genes and Key Regulators Associated With Trypanotolerance in the Sheko Breed (2019) · cites this paper as Pulst, 2016

    The main text (page not given) states that TTC3 regulates Akt signaling. It does not mention immune tolerance or neuronal cell survival, so those parts of the claim are not supported by this paper. (LLM, conf=0.90)

    Experimental — accuracy not yet measured
  • Activated AKT is a mediator of neuronal cell survival.

    “In addition, activated AKT is a mediator of neuronal cell survival (Liu et al., 2002; Chen et al., 2003; Pulst, 2016).”

    From Identification of Candidate Signature Genes and Key Regulators Associated With Trypanotolerance in the Sheko Breed (2019) · cites this paper as Pulst, 2016

    The section “Genetics of neurodegenerative diseases” (page not provided) calls Akt signaling a key pathway disrupted in late-onset Alzheimer disease. It does not address whether activated AKT mediates neuronal cell survival; searches for activated AKT and neuronal survival found no such passage. (LLM, conf=0.76)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

No references could be resolved yet.

Research works printed but not linked: 4

  1. [1]Kohli MA Cukier HN Hamilton-Nelson KL Segregation of a rare TTC3 variant in an extended family with late-onset Alzheimer disease. Neurol Genet 2016; 2: e41. 10.1212/NXG.0000000000000041. 27066578 PMC4817909 · DOI
  2. [2]Nuytemans K Maldonado L Ali A Overlap between Parkinson disease and Alzheimer disease in ABCA7 functional variants. Neurol Genet 2016; 2: e44. 10.1212/NXG.0000000000000044. 27066581 PMC4817903 · DOI
  3. [3]Mano KK Matsukawa T Mitsui J Atypical parkinsonism caused by Pro105Leu mutation of prion protein: a broad clinical spectrum. Neurol Genet 2016; 2: e48. 10.1212/NXG.0000000000000048. 27066585 PMC4817902 · DOI
  4. [4]Ameur F Colliot O Caroppo P White matter lesions in FTLD: distinct phenotypes characterize GRN and C9ORF72 mutations. Neurol Genet 2016; 2: e47. 10.1212/NXG.0000000000000047. 27066584 PMC4817905 · DOI

Cited by

Sorted by citations

Authors
Pulst, S. M.
Affiliations
University of Utah (US)
Corresponding author
Pulst, Stefan M.
Venue
Neurology Genetics
Published
2016-02
Volume
2
Issue
1
Pages
e52-e52
ISSN
2376-7839 (ISSN-L)
OpenAlex
W2304053011
Cited by
1
References
0
Citations by year
2019: 1
FWCI
0.25
Type
journal article
Language
en
Open access
Licence
cc-by-nc-nd
Locations
  • Neurology Genetics (publishedVersion, cc-by-nc-nd)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Neurology › Amyotrophic Lateral Sclerosis Research
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Hereditary Neurological Disorders
Keywords
neurodegenerative diseases, genetic mutations, PRNP gene, prion disease, frontotemporal lobar degeneration, genetic variants, phenotypic variability, neuroimaging phenotypes

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review